TABLE 1.
Imaging model | Nanomaterials | Size (nm) | DLS (nm) | Polydis-persity index | Zeta potential (mV) | Surface area (m2/g) | Pore size (nm) | Pore volume (cm3/g) | Targeting moiety | Type of cells | Animal models | Concentration of NPs | References |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
US Imaging | mSiO2-MNP | 9.4 ± 1.2 | — | — | — | 136.7 | — | 0.46 | EpCAM aptamer | HepG2 cells | — | 0.05 mg/well | Pilapong et al. (2017) |
GPC-3 SiNPs | 250 | 450 | — | −16 ± 1.7 | — | — | — | GPC-3 targeting peptide | HepG2 cells | — | 0.1 mg/ml | Di Paola et al. (2017) | |
MSNC at Au-PFH-PEG | 250 | 250 | — | — | 230 | 4.5 | 0.4 | — | HCC cells | Rabbit VX2 xenograft; HCC tumor-bearing nude mice | 6 mg/ml | Wang et al. (2013) | |
PA Imaging | HA–SiNP conjugates | 1.99 | — | — | — | — | — | — | Hyaluronate | HepG2 cells | Normal balb/c mouse | 20 mg/ml | Lee et al. (2018) |
Ti3C2at mMSNs | — | 116.4 | — | −30 | 772 | 3.1 | 0.96 | RGD | HCC cells | Tumor-bearing nude mice xenografts | 5 mg/kg | Li et al. (2018b) | |
LBLMSN-ICG | ∼71 | 141.8 ± 51.3 | 0.64 ± 0.04 | −17.98 ± 1.24 | — | — | — | — | HepG2 cells | Male mouse cadavers | 0.2 mg/ml | Chaudhary et al. (2019) | |
Fluo-rescence Imaging | ICG/MSNs-RGD | ∼100 | ∼100 | — | — | — | — | — | RGD | Hep-G2-GFP-fLuc | (Hep-G2-GFP-fLuc) xenograſts | 0.2 mg/ml | Zeng et al. (2016) |
(ICG + S) at mSiO2 | ∼100 | ∼100 | — | ∼-17 | — | — | — | — | H22 cells | Female C57BL/6J mice | 1 mg/ml | Yang et al. (2020) | |
Fluorescent Conjugated Polyelectrolyte-Capped MSN | ∼100 | 204 | 0.22 | — | 920 | 2.5 | — | — | HepG2 cells | — | 0.28 mg/ml | Pu et al. (2013) | |
C6PF BP-PPV PDHFBT MEH-PPV | 26.7; 24.3; 25.1; 22.9 | 65.4; 51.4; 62.3; 51.3 | 0.169; 0.143; 0.18; 0.168 | — | — | — | — | — | HepG2 cells | — | 0.06 mg/ml | Tan et al. (2011) | |
PhENH2-MoS2-FA MSNs | 180 | 220 | — | -35 | — | — | — | Folic acid | HepG2 cells | — | 0.0065 mg/ml | Wang et al. (2019b) | |
MR Imaging | PEGylation of Mn-HMSNs | 100 | 141 | — | — | 222 | 3.8 | 0.53 | — | HepG2 cells | Female BALB/c nude mice | 2.5 mg/kg | Yu et al. (2016) |
Mn-SiO2 | 25 | — | — | — | — | — | — | — | HepG2 cells | Orthotopic xenograft model | 3 mg/kg | Kim et al. (2013) | |
M-DMSN at pLAMA | 250 | — | — | — | 119 | — | 0.08 | Glycopolymer | HepG2 cells | Male BALB/c nude mice | 100 mg/kg | An et al. (2015) | |
M-LPMSNs | 120 | — | — | — | — | 7 | — | Folic acid | SMMC-7721 cells | Female BALB/c mice | 2 mg Fe/cm3 tumor | Chi et al. (2019) | |
S-M-MSNs | 250 | — | — | — | 453.6 | 2.8 | 0.32 | — | HepG2 cells | HepG2 xenograft-bearing nude mouse | 25 mg/kg | Wang et al. (2018) | |
R-M-MSNs | 100*300 | — | — | — | 655.7 | — | 0.43 | — | — | — | — | — | |
IONP at MSN-N3 | 170 | ∼170 | — | −30 | 767.17 | 3.04 | 0.576 | — | HepG2 cells; HL-7702 cells | HepG-2 tumor-bearing mice | 5.7 mg/kg | Liu et al. (2020a) | |
CT Imaging | GSJNs | 225*110 | — | — | — | 758.5 | 2.4 | 0.51 | Folic acid | SMMC-7721 cells; HL-7702 cells | SMMC-7721 xenografts nude mice | 5 mg/ml | Wang et al. (2017) |
Au at Si-5-FU | — | 48.27 | 0.2 | 11.43 | 191.6 | 2.9 | 0.35 | EpCAM | HepG2 cells | HepG2 tumor-bearing nude mice | [Au] = 2 mM | Babaei et al. (2017) | |
DMSSs | — | — | — | — | 790.2 | 21.7 | 1.35 | — | SMMC-7721 cells | SMMC-7721 xenografts nude mice | [Au] = 5.3 mg/ml | Qin et al. (2019) | |
Multi-modal imaging | Fe3O4 at PMO | 362 ± 21 | 406 | −31.4 | 539 | 2.9 | 0.694 | — | HepG2 cells | Rabbit VX2 xenograft | 0.02 mg/ml | Liu et al. (2021) | |
UCMSs | ∼50 | — | — | −7 | 814 | 30 | 2.053 | — | HepG2 cells | H22 tumor- bearing BALB/c mice | [Mn] = 0.6 mM | Ding et al. (2019) | |
GdIO at mSiO2 | 40 ± 2 | — | — | 24 | 410.95 | 3.6 | — | — | HepG2 cells | — | 0.03 mg/ml | Das et al. (2018) |